TY - JOUR
KW - Self-harm
KW - Suicide
KW - opioid agonist treatment
KW - primary care patients
KW - opioid dependence
KW - Empirical Study
KW - Longitudinal Study
KW - Retrospective Study
KW - Quantitative Study
KW - Human
KW - Male
KW - Female
KW - Adulthood (18 yrs & older)
KW - Young Adulthood (18-29 yrs)
KW - Thirties (30-39 yrs)
KW - Middle Age (40-64 yrs)
KW - Aged (65 yrs & older)
KW - Narcotic Agonists
KW - opioid use disorder
KW - Drug Therapy
KW - Self-Injurious Behavior
KW - Primary Health Care
KW - Substance use treatment
KW - England
KW - article
KW - 3383:Drug & Alcohol Rehabilitation
AU - Prianka Padmanathan
AU - Harriet Forbes
AU - Maria Theresa Redaniel
AU - David Gunnell
AU - Dan Lewer
AU - Paul Moran
AU - Ben Watson
AU - Louisa Degenhardt
AU - Matthew Hickman
A1 - 
AD - Bristol Medical School, University of Bristol, Bristol, United Kingdom prianka.padmanathan@bristol.ac.uk; Institute of Epidemiology and Healthcare, University College London, London, United Kingdom ; Bristol Specialist Drug and Alcohol Service, Avon and Wiltshire Mental Health Partnership NHS Trust, Bath, United Kingdom ; National Drug and Alcohol Research Centre, University of New South Wales Sydney, Sydney, NSW, Australia ; Padmanathan, Prianka,Bristol,United Kingdom,BS8 1UD,Bristol Medical School, University of Bristol,prianka.padmanathan@bristol.ac.uk
BT - The Lancet Psychiatry
C5 - Opioids & Substance Use
CP - 2
DO - 10.1016/S2215-0366(21)00392-8
IS - 2
JF - The Lancet Psychiatry
LA - English
M1 - Journal Article
PY - 2022
SN - 2215-0366, 2215-0366
SP - 151
EP - 159
EP - 
T1 - Self-harm and suicide during and after opioid agonist treatment among primary care patients in England: A cohort study
T2 - The Lancet Psychiatry
TI - Self-harm and suicide during and after opioid agonist treatment among primary care patients in England: A cohort study
U1 - Opioids & Substance Use
U3 - 10.1016/S2215-0366(21)00392-8
VL - 9
VO - 2215-0366, 2215-0366
Y1 - 2022
Y2 - 02
ER -